Cargando…

Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial

Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (−)-epicatechin, and procyanidins and more (−)-catechin than nonalkalized cocoa powd...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellinger, Sabine, Reusch, Andreas, Henckes, Lisa, Ritter, Christina, Zimmermann, Benno F., Ellinger, Jörg, Galensa, Rudolf, Stehle, Peter, Helfrich, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020035/
https://www.ncbi.nlm.nih.gov/pubmed/31963163
http://dx.doi.org/10.3390/nu12010231
_version_ 1783497658432749568
author Ellinger, Sabine
Reusch, Andreas
Henckes, Lisa
Ritter, Christina
Zimmermann, Benno F.
Ellinger, Jörg
Galensa, Rudolf
Stehle, Peter
Helfrich, Hans-Peter
author_facet Ellinger, Sabine
Reusch, Andreas
Henckes, Lisa
Ritter, Christina
Zimmermann, Benno F.
Ellinger, Jörg
Galensa, Rudolf
Stehle, Peter
Helfrich, Hans-Peter
author_sort Ellinger, Sabine
collection PubMed
description Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (−)-epicatechin, and procyanidins and more (−)-catechin than nonalkalized cocoa powder (NALC). This may affect the plasma appearance of monomeric flavan-3-ol stereoisomers after consumption of NALC vs. ALC. Within a randomized, crossover trial, 12 healthy nonsmokers ingested a milk-based cocoa beverage providing either NALC or ALC. Blood was collected before and within 6 h postconsumption. (+)-Catechin, (−)-catechin, and epicatechin were analyzed in plasma by HPLC as sum of free and glucuronidated metabolites. Pharmacokinetic parameters were obtained by a one-compartment model with nonlinear regression methods. For epicatechin in plasma, total area under the curve within 6 h postconsumption (AUC(0–6h)) and incremental AUC(0–6h) were additionally calculated by using the linear trapezoidal method. After consumption of NALC and ALC, (+)-catechin and (−)-catechin were mostly not detectable in plasma, in contrast to epicatechin. For epicatechin, total AUC(0–6h) was different between both treatments, but not incremental AUC(0–6h). Most kinetic parameters were similar for both treatments, but they varied strongly between individuals. Thus, epicatechin is the main monomeric flavan-3-ol in plasma after cocoa consumption. Whether NALC should be preferred against ALC due to its higher (−)-epicatechin content remains unclear with regard to the results on incremental AUC(0–6h). Future studies should investigate epicatechin metabolites in plasma for a period up to 24 h in a larger sample size, taking into account genetic polymorphisms in epicatechin metabolism and should consider all metabolites to understand inter-individual differences after cocoa intake.
format Online
Article
Text
id pubmed-7020035
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70200352020-03-09 Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial Ellinger, Sabine Reusch, Andreas Henckes, Lisa Ritter, Christina Zimmermann, Benno F. Ellinger, Jörg Galensa, Rudolf Stehle, Peter Helfrich, Hans-Peter Nutrients Article Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (−)-epicatechin, and procyanidins and more (−)-catechin than nonalkalized cocoa powder (NALC). This may affect the plasma appearance of monomeric flavan-3-ol stereoisomers after consumption of NALC vs. ALC. Within a randomized, crossover trial, 12 healthy nonsmokers ingested a milk-based cocoa beverage providing either NALC or ALC. Blood was collected before and within 6 h postconsumption. (+)-Catechin, (−)-catechin, and epicatechin were analyzed in plasma by HPLC as sum of free and glucuronidated metabolites. Pharmacokinetic parameters were obtained by a one-compartment model with nonlinear regression methods. For epicatechin in plasma, total area under the curve within 6 h postconsumption (AUC(0–6h)) and incremental AUC(0–6h) were additionally calculated by using the linear trapezoidal method. After consumption of NALC and ALC, (+)-catechin and (−)-catechin were mostly not detectable in plasma, in contrast to epicatechin. For epicatechin, total AUC(0–6h) was different between both treatments, but not incremental AUC(0–6h). Most kinetic parameters were similar for both treatments, but they varied strongly between individuals. Thus, epicatechin is the main monomeric flavan-3-ol in plasma after cocoa consumption. Whether NALC should be preferred against ALC due to its higher (−)-epicatechin content remains unclear with regard to the results on incremental AUC(0–6h). Future studies should investigate epicatechin metabolites in plasma for a period up to 24 h in a larger sample size, taking into account genetic polymorphisms in epicatechin metabolism and should consider all metabolites to understand inter-individual differences after cocoa intake. MDPI 2020-01-16 /pmc/articles/PMC7020035/ /pubmed/31963163 http://dx.doi.org/10.3390/nu12010231 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ellinger, Sabine
Reusch, Andreas
Henckes, Lisa
Ritter, Christina
Zimmermann, Benno F.
Ellinger, Jörg
Galensa, Rudolf
Stehle, Peter
Helfrich, Hans-Peter
Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial
title Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial
title_full Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial
title_fullStr Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial
title_full_unstemmed Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial
title_short Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial
title_sort low plasma appearance of (+)-catechin and (−)-catechin compared with epicatechin after consumption of beverages prepared from nonalkalized or alkalized cocoa—a randomized, double-blind trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020035/
https://www.ncbi.nlm.nih.gov/pubmed/31963163
http://dx.doi.org/10.3390/nu12010231
work_keys_str_mv AT ellingersabine lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT reuschandreas lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT henckeslisa lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT ritterchristina lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT zimmermannbennof lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT ellingerjorg lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT galensarudolf lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT stehlepeter lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial
AT helfrichhanspeter lowplasmaappearanceofcatechinandcatechincomparedwithepicatechinafterconsumptionofbeveragespreparedfromnonalkalizedoralkalizedcocoaarandomizeddoubleblindtrial